Cargando…
Anti-IgE Treatment for Disorders Other Than Asthma
Immunoglobulin E (IgE) plays a key role in the pathogenesis of many allergic diseases. Thus, IgE-mediated immunologic pathways are an attractive target for intervention in allergic diseases. Omalizumab is a recombinant humanized monoclonal antibody that binds IgE and has been used treat allergic ast...
Autor principal: | Stokes, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613080/ https://www.ncbi.nlm.nih.gov/pubmed/28983485 http://dx.doi.org/10.3389/fmed.2017.00152 |
Ejemplares similares
-
Anti- IgE treatment in asthma: is atopy essential?
por: Gulec, Mustafa, et al.
Publicado: (2015) -
Severe asthma: anti-IgE or anti-IL-5?
por: Papathanassiou, Evgenia, et al.
Publicado: (2016) -
IgE-Related Chronic Diseases and Anti-IgE-Based Treatments
por: Navinés-Ferrer, Arnau, et al.
Publicado: (2016) -
Inhibition of IgE and IgE/anti-IgE mediated responses in mast cells by Omalizumab
por: Kulka, M, et al.
Publicado: (2010) -
Cumulative IgE-levels specific for respiratory allergens as biomarker to predict efficacy of anti-IgE-based treatment of severe asthma
por: Naumova, Veronika, et al.
Publicado: (2022)